Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 28 citing articles:

Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells
Pankaj Garg, Jyoti Malhotra, Prakash Kulkarni, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2478-2478
Open Access | Times Cited: 21
Biomarker-Targeted Therapies in Non–Small Cell Lung Cancer: Current Status and Perspectives
Haiyang Guo, Jun Zhang, Chao Qin, et al.
Cells (2022) Vol. 11, Iss. 20, pp. 3200-3200
Open Access | Times Cited: 46
Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions
Nuno Jorge Lamas, Arnaud Martel, Sacha Nahon‐Estève, et al.
Cancers (2021) Vol. 14, Iss. 1, pp. 96-96
Open Access | Times Cited: 41
Current challenges and practical aspects of molecular pathology for non-small cell lung cancers
Paul Hofman, Sabina Berezowska, Daniel Kazdal, et al.
Virchows Archiv (2023) Vol. 484, Iss. 2, pp. 233-246
Open Access | Times Cited: 18
Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer
Umberto Malapelle, Natasha B. Leighl, Alfredo Addeo, et al.
British Journal of Cancer (2024) Vol. 131, Iss. 2, pp. 212-219
Open Access | Times Cited: 6
Setting Up an Ultra-Fast Next-Generation Sequencing Approach as Reflex Testing at Diagnosis of Non-Squamous Non-Small Cell Lung Cancer; Experience of a Single Center (LPCE, Nice, France)
Marius Ilié, Véronique Hofman, Christophe Bontoux, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2258-2258
Open Access | Times Cited: 25
A Prospective Validation Study of Lung Cancer Gene Panel Testing Using Cytological Specimens
Kei Morikawa, Hirotaka Kida, Hiroshi Handa, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3784-3784
Open Access | Times Cited: 23
Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study
Marco Sposito, Lorenzo Belluomini, Riccardo Nocini, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Relevance of Circulating Tumor Cells as Predictive Markers for Cancer Incidence and Relapse
Chaithanya Chelakkot, Hobin Yang, Young Kee Shin
Pharmaceuticals (2022) Vol. 15, Iss. 1, pp. 75-75
Open Access | Times Cited: 15
Morphologic-Molecular Transformation of Oncogene Addicted Non-Small Cell Lung Cancer
Fiorella Calabrese, Federica Pezzuto, Francesca Lunardi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4164-4164
Open Access | Times Cited: 15
Enhancing Lung Cancer Care in Portugal: Bridging Gaps for Improved Patient Outcomes
Raquel Ramos, Conceição Souto Moura, Mariana Fernandes Costa, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 5, pp. 446-446
Open Access | Times Cited: 2
Integration of liquid biopsy and pharmacogenomics for precision therapy of EGFR mutant and resistant lung cancers
Jill Kolesar, Keng Hee Peh, Levin Thomas, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 12
Daily Practice Assessment of KRAS Status in NSCLC Patients: A New Challenge for the Thoracic Pathologist Is Right around the Corner
Christophe Bontoux, Véronique Hofman, Patrick Brest, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1628-1628
Open Access | Times Cited: 12
Matched tissue and liquid biopsies for advanced non-small cell lung cancer patients A potentially indispensable complementary approach
Paul Hofman
Translational Oncology (2023) Vol. 35, pp. 101735-101735
Open Access | Times Cited: 7
Liquid and Tissue Biopsies for Lung Cancer: Algorithms and Perspectives
Paul Hofman
Cancers (2024) Vol. 16, Iss. 19, pp. 3340-3340
Open Access | Times Cited: 1
What Is New in Biomarker Testing at Diagnosis of Advanced Non-Squamous Non-Small Cell Lung Carcinoma? Implications for Cytology and Liquid Biopsy
Paul Hofman
Journal of Molecular Pathology (2021) Vol. 2, Iss. 2, pp. 147-172
Open Access | Times Cited: 11
Loss of Rb1 Associated With the Onset of Acquired Resistance to Trastuzumab Deruxtecan in TP53-/HER2-Mutated Non–Small-Cell Lung Cancer: Case Series
Ashish Gupta, Karan Jatwani, Kush Gupta, et al.
JCO Precision Oncology (2023), Iss. 7
Closed Access | Times Cited: 2
Implementation of the clinical practice of liquid biopsies for thoracic oncology the experience of the RespirERA university hospital institute (Nice, France)
Paul Hofman
The Journal of Liquid Biopsy (2023) Vol. 1, pp. 100004-100004
Open Access | Times Cited: 2
EGFR Status Assessment for Better Care of Early Stage Non-Small Cell Lung Carcinoma: What Is Changing in the Daily Practice of Pathologists?
Paul Hofman
Cells (2021) Vol. 10, Iss. 8, pp. 2157-2157
Open Access | Times Cited: 6
Cancer nanoimmunotherapy in the present scenario
Alejandra Ancira-Cortez, Brenda Gibbens-Bandala, Pedro Cruz-Nova, et al.
Elsevier eBooks (2024), pp. 653-681
Closed Access
Implementation of an ISO 15189 accredited next generation sequencing service for cell-free total nucleic acid (cfTNA) analysis to facilitate driver mutation reporting in blood: the experience of a clinical diagnostic laboratory
Réiltín Werner, Ruth Crosbie, Mairead Dorney, et al.
Journal of Clinical Pathology (2024), pp. jcp-209514
Open Access
Biopsie liquide et/ou biopsie tissulaire en oncologie thoracique : algorithmes et perspectives
Paul Hofman
Revue Francophone des Laboratoires (2024) Vol. 2024, Iss. 567, pp. 52-60
Closed Access
„Liquid biopsy“ – Pionierarbeit in der Ophthalmologie
Salvatore Grisanti
Deleted Journal (2024) Vol. 121, Iss. 12, pp. 944-945
Open Access
Diagnostic and Predictive Biomarkers in Lung Cancer
Caterina Fumagalli, Massimo Barberis
Cancers (2021) Vol. 13, Iss. 11, pp. 2577-2577
Open Access | Times Cited: 4
L’évaluation des mutations de l’EGFR des carcinomes non à petites cellules de stade précoce
Véronique Hofman, Samantha Goffinet, Christophe Bontoux, et al.
Revue Francophone des Laboratoires (2021) Vol. 2022, Iss. 538, pp. 49-55
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top